World-Class Excellence! Runjian Co., Ltd. and Guangxi Medical University Rank Among Top 5% Globally in AI Comprehensive Algorithm Ranking

Following DeepMind's AlphaFold technology winning the 2024 Nobel Prize in Chemistry, global artificial intelligence is profoundly reshaping the landscape of biomedical research. The “Virtual Cell” is regarded as the next scientific frontier beyond protein structure prediction, while the research direction dubbed the “ultimate Virtual Cell” is widely recognized by the international scientific community as highly likely to continue making Nobel Prize-level breakthroughs in the future, fundamentally transforming the research paradigm in biomedicine.

Recently, in the globally acclaimed “Medical Virtual Cell” strategic competition, a joint research team formed by Runjian Co., Ltd. and Guangxi Medical University actively participated in the Virtual Cell Challenge—hailed as the pinnacle of medical artificial intelligence competitions. They competed alongside teams from world-renowned universities such as Harvard, Yale, and Stanford, as well as leading global AI laboratories and top life science research institutions. Ultimately, the Ruanjian-Guangxi Medical University joint team emerged from 5,121 top medical AI research teams across 114 countries and regions. Their core metric DES (0.29) ranked 35th globally, while their overall algorithm placement secured a spot within the top 5% worldwide, earning recognition from this premier international technology competition.

On June 26, 2025, researchers from the internationally renowned AI laboratory Arc Institute published a paper titled “Virtual Cell Challenge: Toward a Turing Test for the Virtual Cell” in the top-tier academic journal Cell. This article formally launched the Virtual Cell Challenge, whose core objective is to provide a fair and open testing framework. Toward a Turing Test for the Virtual Cell. This commentary formally launched the Virtual Cell Challenge, whose core objective is to provide a fair and open evaluation framework to identify the best virtual cell models capable of passing rigorous testing. The initiative aims to unite global scientific efforts to tackle the challenges of virtual cell modeling and accelerate the transition from laboratory research to practical applications.

Virtual cells represent the core engineering project for constructing a digital life medical system, regarded as indispensable infrastructure for future precision medicine, drug development, disease modeling, and diagnostic treatment. International experts widely agree that mastering core virtual cell technologies will secure a strategic vantage point in the era of biomedical and artificial intelligence convergence.

The launch of the Virtual Cell Challenge marks an exciting new phase in AI-empowered life sciences. It is not merely a competition, but a pivotal step in building the foundation for future digital biology. When AI virtual cells can pass rigorous “Turing tests” and accurately predict the behavior of life's most fundamental units, humanity's understanding and ability to intervene in life will enter an unprecedented new era.

Virtual Cell Challenge Overview (Source: Cell): In the Virtual Cell Challenge, participants will develop virtual cell models to predict the effects of genetic and chemical perturbations on transcriptional activity within cell populations. Given an unperturbed cellular state, the task involves inferring how gene expression responds to specific perturbations.

In this world-class medical AI competition, the joint team from Runjian Co., Ltd. and Guangxi Medical University demonstrated its capability to independently master core medical AI algorithm modeling technologies, possessing a complete technical solution spanning from foundational model construction to system-level biomedical simulation. This achievement not only signifies the deep integration of Runjian Co., Ltd.'s AI capabilities with Guangxi Medical University's cutting-edge research but also demonstrates the team's capacity to compete with the world's strongest medical AI laboratories on key technologies and achieve partial surpassing.

Runjian Co., Ltd. and Guangxi Medical University achieved outstanding results in an international AI competition, propelling Guangxi's medical artificial intelligence onto the global stage as a leading force in the field and a significant representative of China's capabilities. This accomplishment not only signifies high recognition of Runjian's AI technological prowess and industry application achievements but also affirms the company's innovative leadership role in regional industrial development. Runjian will continue advancing algorithm and model optimization to deliver more internationally influential original innovations across multiple industry sectors.

Runjian Co., Ltd. is committed to becoming an industry-leading provider of artificial intelligence models and computing power services, having established a comprehensive AI service ecosystem spanning the entire chain from data to models, intelligent agents, applications, and operations. Moving forward, the company will continue to uphold its core strategy of “AI-driven, green computing synergy, and intelligent maintenance for all industries.” It will intensify R&D investment and innovation exploration in the AI field, continuously expand the boundaries of AI-empowered industries, and help Chinese technologies and solutions reach the global stage. Runjian will contribute Chinese wisdom and strength to the world's digital development!